Dr. Everson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Wasserman Building
300 Stein Plaza, Suite 420
Los Angeles, CA 90095Phone+1 310-825-5111Fax+1 310-825-5111
Summary
- Dr. Everson has expertise in the surgical treatment of primary and metastatic tumors of the brain, spine and skull base. He works with multidisciplinary oncology teams to individualize patient treatments. Dr. Everson employs the full range of minimally invasive, image-guided, endoscopic, radiosurgery, microsurgical, conventional open and reconstructive techniques to ensure both maximum tumor removal and patient safety. His research focuses on immunotherapy and clinical trials for brain tumors.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Neurosurgical Oncology, 2016 - 2017
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurological Surgery, 2009 - 2016
- Duke University School of MedicineClass of 2009
- University of Michigan Medical SchoolBS, Cellular and Molecular Biology, 2005
Certifications & Licensure
- CA State Medical License 2011 - 2025
- NV State Medical License 2023 - 2025
- TX State Medical License 2016 - 2025
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Brian D. Silber Award (AANS) 2017
- California Association of Neurological Surgeons Best Abstract Award 2016
- UCLA Neurosurgery Resident Award for Academic Excellence 2013
- Join now to see all
Publications & Presentations
PubMed
- 129 citationsTherapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort AnalysisVijay Ramaswamy, Thomas Hielscher, Stephen C. Mack, Alvaro Lassaletta, Tong Lin
Journal of Clinical Oncology. 2016-07-20 - 5 citationsTLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial.Richard G Everson, Willy Hugo, Lu Sun, Joseph Antonios, Alexander Lee
Nature Communications. 2024-05-08 - 116 citationsNeoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastomaAlexander Lee, Lu Sun, Aaron Mochizuki, Jeremy Reynoso, Joey Orpilla
Nature Communications. 2021-11-26
Journal Articles
- Chiari I Malformation in the AdultEverson, RG, Holly, LT, and Batzdorf, U, Neurosurgery Quarterly, 1/1/2015
Books/Book Chapters
Abstracts/Posters
- Laser Thermotherapy for Spinal Metastatic Disease provides Comparable Local Control, Reduced Morbidity and Delay to Systemic Therapy Compared to Open SurgeryEverson RG, Feranandes B, Zuckerman S, Rao G, Li J, Ghia A, Amini B, Rhines, L, Tatsui CE, 85th American Association of Neurological Surgeons Annual Meeting, 1/1/2017
- Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients with Long-term Follow-upZuckerman S, Chang G, Walsh G, Mehran R, Everson R, Lee S, Rao G, Tatsui C, Rhines L, The Congress of Neurological Surgeons Spine Summit 2017 - 33rd Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves, 1/1/2017
- Interbody distraction and vertebral body reconstruction with PMMA for the treatment of pathologic fracturesZuckerman S, Everson R, Rao G, McCutcheon I, Rhines L, Tatsui C, The Congress of Neurological Surgeons Spine Summit 2017 - 33rd Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves, 1/1/2017
- Join now to see all
Lectures
- Laser Thermotherapy for Spinal Metastatic Disease provides Comparable Local Control, Reduced Morbidity and Less Delay to Systemic Therapy Compared to Open SurgeryLos Angeles, CA - 1/1/2017
- Emerging Approaches in Brain Tumor ImmunotherapyLos Angeles, CA - 1/1/2017
- PD-1 Inhibition Enhances Dendritic Cell Vaccine-Generated Anti-Tumor Immune Response against GlioblastomaPismo Beach, CA - 1/1/2016
- Join now to see all
Press Mentions
- Adding Immune-Boosting Agent to Personalised Cancer Vaccine Supercharges the Body's Immune Defense Against Malignant Brain TumoursMay 10th, 2024
- New Technique Gives a Clearer Image of Immunotherapy Results in Advanced Brain CancerSeptember 5th, 2017
Professional Memberships
- Member
- Member
- Society for Neuro-OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: